AHA Scientific Sessions 2026 Abstract · Nov 2, 2026
Pulmonary Embolism Mortality Associated with Tobacco Use in the United States 1999-2025: Trends, Disparities, and Projections to 2040
By Eltablawy Aly Ahmed M, Elbanna AF, Fawad M et al.
Background: Pulmonary embolism (PE) is one of the life-threatening cardiovascular conditions and remains a significant public health burden. Tobacco use is a well-established risk factor for thromboembolic events including PE; however national trends in PE mortality associated with tobacco use remain poorly understood. Methods: We performed a retrospective analysis using U.S. national mortality data (1999-2025) to identify deaths with PE-associated with tobacco use among adults ≥25 years. Age-adjusted mortality rates (AAMR) and crude mortality rates (CMR) were calculated. Trends were assessed using joinpoint regression to estimate annual percent change (APC) and average annual percent change (AAPC). Forecasting analyses estimated future mortality trends through 2040 using time-series projection methods. Results: A total of 92,796 deaths were listed among U.S. adults aged ≥25 years with PE and tobacco use (1999-2025). Overall mortality significantly increased (AAMR: 0.12 to 2.25; AAPC 13.35%; p < 0.01). Males showed higher AAMRs (0.17 in 1999 to 2.88 in 2025) when compared to females (0.07 in 1999 to 1.73 in 2025). Racially, the highest mortality burden occurred in non-Hispanic (NH) Blacks with AAMRs (0.16 in 1999; 3.06 in 2025). Older adults aged ≥65 years had the highest mortality, with CMR increasing from 0.37 to 7.37 (AAPC:12.02%; p = 0.02). Regarding the place of death, inpatient medical facilities were the most frequent location with 43,796 deaths (51.7%). Forecasts project AAMR to reach 3.64 by 2040. Conclusion: PE mortality associated with tobacco use significantly increased and is projected to increase through 2040. However, persistent disparities among men, NH Blacks, and older adults necessitate targeted prevention and management to improve outcomes.